Color Does Matter – For Pills
Source There is a certain logic that suggests patients may have a different view of a new pill used to treat an existing malady from a pill taken previously, especially if they do not resemble one another. But there was never any hard evidence to suggest that such a switch would affect adherence negatively, until […]
Read More »Category : News
Suspect Animal Deaths at Drug Labs
source The US Department of Agriculture plans to inspect facilities run by three companies that conduct animal research for pharmaceutical products – Merck, Wuxi Apptec and Charles River Laboratories – following reports of deaths of more than a dozen animals in their labs over the past three years, including rabbits, monkeys and a dog. How […]
Read More »Category : News
Excessive Private Jet For Pop Star Use at Mylan?
source For the past few years, Mylan ceo Bob Coury has faced scrutiny over his use of corporate jets after racking up rather impressive bills. Last year, the drugmaker paid $500,779 so he could galavant. The year before, it was $535,590, up from $433,387 in 2009 and $348,988 in 2008, according to filings with the […]
Read More »Category : News
Pfizer Pulls Another Paper Involving Failed Drug
For the second time in as many months, Pfizer has retracted a paper about an experimental treatment for lung cancer, which is no longer being developed. Both papers involved the same study and a former Pfizer scientist was listed as a co-author and clinical lead, according to Retraction Watch. How To Survive an FDA Inspection […]
Read More »Category : News
FDA Reaction to Amarin Fish Oil Pill Expected
source Today may be a turning point in one of the more captivating stock stories to unfold in the pharmaceutical industry this year. Why? The FDA may finally issue a decision on whether to grant new molecular entity status to Vascepa, a fish oil pill sold by Amarin and which was approved last July by […]
Read More »Category : News
Servier Labs Founder Faces Possible Manslaughter Charges
Source In a rare move not seen in the pharmaceutical industry, Jacques Servier, who founded Servier Laboratories, was formally placed under investigation on suspicion of manslaughter in connection with his role in the scandal over the Mediator diabetes drug, whic has been blamed for at least 500 deaths in France, Reutersreports. The 90-year-old Service was […]
Read More »Category : News
Did FDA Miss Clues in New England Compounding Audits?
Source Two months ago, the FDA inspected the New England Compounding Center, the pharmacy that has been linked to 590 cases of fungal meningitis, including 37 deaths (see this), and found a variety of disturbing conditions. These included ‘greenish-black foreign matter’ on sterilization equipment and air conditioning that was turned off each night despite the […]
Read More »Category : News
Primatene Mist Denied Comeback
source After months of anticipation, the US House of Representatives late yesterday voted down a bill that would have permitted Amphastar Pharmaceuticals to return the Primatene Mist over-the-counter asthma inhaler to the US market in order to sell off its inventory of some 1.5 million units. The vote was 229-to-182. The move is a setback […]
Read More »Category : News
Boehringer Sued by Hundreds Over Bleeding Tied to Pradaxa
Harold Asher never thought to ask why his wife’s doctors prescribed Boehringer Ingelheim GmbH’s blood thinner Pradaxa after she recovered from a stroke. Barbara Jean Asher took Pradaxa for three months to cut her risk of suffering another stroke. Then, in June 2011, she was rushed to a hospital with internal bleeding that proved fatal, […]
Read More »Category : News
Phamacy behind fungal outbreak pushed hard to expand, newspaper reports
Regulators repeatedly passed up opportunities to crack down on a Massachusetts pharmacy blamed for an outbreak of fungal meningitis that has killed 36 people and made 541 sick, the Boston Globe reported Monday. Barry Cadden, the pharmacist who started up the New England Compounding Center, boasted about taking the pharmacy national even as he promised […]
Read More »Category : News
